TheratechnologiesのEBITDA margin
TheratechnologiesのEBITDA marginは何ですか。
Theratechnologies, Inc.のEBITDA marginは-27.40%です。
EBITDA marginの定義は何ですか。
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
TSXのセクタHealth CareにおけるEBITDA marginの企業と比べるTheratechnologies
Theratechnologiesは何をしますか。
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Theratechnologiesと類似のebitda margin
- QYOU MediaのEBITDA marginは-27.60%です。
- AppianのEBITDA marginは-27.58%です。
- FLYHT Aerospace SolutionsのEBITDA marginは-27.53%です。
- Axion VenturesのEBITDA marginは-27.49%です。
- Tejas NetworksのEBITDA marginは-27.41%です。
- SiTime CorpのEBITDA marginは-27.41%です。
- TheratechnologiesのEBITDA marginは-27.40%です。
- China Shenghai FoodのEBITDA marginは-27.31%です。
- ImmunogenのEBITDA marginは-27.28%です。
- ARSS Infrastructure ProjectsのEBITDA marginは-27.27%です。
- QuickLogicのEBITDA marginは-27.23%です。
- Accel TransmaticのEBITDA marginは-27.21%です。
- Sanara MedTechのEBITDA marginは-27.20%です。